[2] Anastrozole was first approved in 1995 for treating advanced breast cancer in postmenopausal patients whose disease had progressed on tamoxifen therapy, and it later gained approval for first line use in metastatic disease (2000) and as adjuvant therapy in early-stage breast cancer (2002)
For families navigating pediatric weight management, liraglutide remains the established option with the most safety data in younger populations
Ask them to confirm manufacturer sourcing and standard packaging
Glutathione has several functions that make it an essential tool for fighting oxidative stress 1
Get expert guidance on dosage, benefits, side effects, and medically supervised weight management
Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features